35,618 Shares in Tempus AI, Inc. $TEM Bought by Strs Ohio

Key Points

• Strs Ohio invested approximately $1.72 million in Tempus AI, acquiring 35,618 shares in the first quarter of the year.
• Several institutional investors have also made moves regarding Tempus AI, with 24.22% of the company's stock currently held by these entities.
• Wall Street analysts maintain a consensus rating of "Moderate Buy" for Tempus AI, with an average target price of $70.17.

Strs Ohio purchased a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 35,618 shares of the company's stock, valued at approximately $1,718,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Ameriprise Financial Inc. bought a new stake in Tempus AI during the fourth quarter worth approximately $8,789,000. BNP Paribas Financial Markets acquired a new position in shares of Tempus AI in the 4th quarter worth approximately $78,000. Lazard Asset Management LLC acquired a new position in shares of Tempus AI in the 4th quarter worth approximately $1,034,000. ProShare Advisors LLC acquired a new stake in shares of Tempus AI in the 4th quarter valued at $244,000. Finally, Two Sigma Advisers LP acquired a new stake in shares of Tempus AI during the fourth quarter worth approximately $625,000. Institutional investors and hedge funds own 24.22% of the company's stock.

Analyst Ratings Changes

Several research analysts recently weighed in on TEM shares. HC Wainwright boosted their price objective on shares of Tempus AI from $90.00 to $98.00 and gave the stock a "buy" rating in a research report on Friday, September 12th. Morgan Stanley lifted their price target on shares of Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a research report on Tuesday, August 12th. BTIG Research lifted their price target on shares of Tempus AI from $75.00 to $85.00 and gave the company a "buy" rating in a research note on Wednesday, August 20th. Piper Sandler reaffirmed a "neutral" rating on shares of Tempus AI in a research report on Friday, August 8th. Finally, Needham & Company LLC restated a "buy" rating and set a $70.00 price objective on shares of Tempus AI in a research note on Friday, August 8th. Seven investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, Tempus AI currently has a consensus rating of "Moderate Buy" and an average price target of $70.17.

Tempus AI Stock Performance

Shares of NASDAQ:TEM traded up $1.17 during trading on Friday, reaching $88.24. 17,651,091 shares of the stock were exchanged, compared to its average volume of 8,194,459. The firm has a market cap of $15.33 billion, a PE ratio of -74.15 and a beta of 5.08. The stock has a 50-day moving average price of $70.46 and a 200-day moving average price of $60.69. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. Tempus AI, Inc. has a 12 month low of $31.36 and a 12 month high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings data on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, topping the consensus estimate of ($0.23) by $0.01. The firm had revenue of $314.64 million for the quarter, compared to analysts' expectations of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The company's quarterly revenue was up 89.5% compared to the same quarter last year. During the same quarter last year, the business earned ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. Research analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Insider Activity at Tempus AI

In other Tempus AI news, EVP Erik Phelps sold 3,664 shares of the company's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $273,517.60. Following the completion of the transaction, the executive vice president owned 94,115 shares of the company's stock, valued at $7,025,684.75. This represents a 3.75% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Eric P. Lefkofsky sold 332,500 shares of the firm's stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $74.10, for a total transaction of $24,638,250.00. Following the transaction, the chief executive officer directly owned 9,207,533 shares of the company's stock, valued at $682,278,195.30. The trade was a 3.49% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 601,787 shares of company stock worth $42,492,268 in the last quarter. 26.27% of the stock is currently owned by corporate insiders.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.